GSK’s Nucala Wins China Approval as First IL‑5 Biologic for COPD
CompanyDrug

GSK’s Nucala Wins China Approval as First IL‑5 Biologic for COPD

EPI-003 Wins FDA IND as First LNP Epigenetic Therapy for Hepatitis B
CompanyDrug

EPI-003 Wins FDA IND as First LNP Epigenetic Therapy for Hepatitis B

SanegeneBio’s INHBE siRNA Wins China IND for Obesity as First RNAi Target
CompanyDrug

SanegeneBio’s INHBE siRNA Wins China IND for Obesity as First RNAi Target

Fosun Pharma Partners with Clavis Bio in $362.5M Strategic Collaboration
CompanyDeals

Fosun Pharma Partners with Clavis Bio in $362.5M Strategic Collaboration

BeOne Medicines Wins FDA Fast Track for GPC3 Bispecific in Liver Cancer
CompanyDrug

BeOne Medicines Wins FDA Fast Track for GPC3 Bispecific in Liver Cancer

BeOne Medicines Names Dual Presidents in Leadership Overhaul
Company

BeOne Medicines Names Dual Presidents in Leadership Overhaul

Leadingtac Raises RMB 200M Series B to Advance Protein Degradation Pipeline
CompanyDeals

Leadingtac Raises RMB 200M Series B to Advance Protein Degradation Pipeline

TransThera NDA Accepted for Tinengotinib in Cholangiocarcinoma After FGFR Inhibitor
CompanyDrug

TransThera NDA Accepted for Tinengotinib in Cholangiocarcinoma After FGFR Inhibitor

Bio‑Thera NDA for VEGF‑A165 Antibody Targets $2B Wet AMD Market in China
CompanyDrug

Bio‑Thera NDA for VEGF‑A165 Antibody Targets $2B Wet AMD Market in China

Novo Nordisk Submits CagriSema NDA for 20% Weight Loss in Obesity
CompanyDrug

Novo Nordisk Submits CagriSema NDA for 20% Weight Loss in Obesity

Neurodawn’s Y-4 Wins FDA Fast Track for First‑in‑Class Neuropathic Pain Combo
CompanyDrug

Neurodawn’s Y-4 Wins FDA Fast Track for First‑in‑Class Neuropathic Pain Combo

Baiyunshan to Acquire Zhejiang Pharma‑Industry for $500.5M, Expanding Distribution Network
CompanyDeals

Baiyunshan to Acquire Zhejiang Pharma‑Industry for $500.5M, Expanding Distribution Network